Weave Communications Announces Employment Inducement Awards in Accordance with NYSE Rule 303A.08

LEHI, Utah—June 6, 2025 – As required by the rules of the New York Stock Exchange, Weave Communications, Inc. (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced that on June 2, 2025, the Compensation Committee of Weave’s Board of Directors granted restricted stock units relating to an aggregate of 512,250 shares of Weave’s common stock to 31 newly hired employees as an inducement for them to join Weave. The employees were hired in connection with Weave’s previously announced acquisition of Vidurama, Inc. (d/b/a TrueLark). These awards vest over three years, with 33% vesting on June 15, 2026 and the remaining 67% vesting over the following two years in equal quarterly installments, subject to continued service through each vesting date.

The employment inducement awards were granted under Weave’s 2022 Inducement Equity Incentive Plan and related form of restricted stock unit agreement in reliance on the employment inducement exception to stockholder approval provided under Section 303A.08 of the NYSE Listed Company Manual. To comply with the terms of this exemption, the employment inducement award requires prompt public announcement of the award and written notice to the NYSE.

About Weave

Weave is a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses. From the first phone call to the final invoice and every touchpoint in between, Weave connects the entire patient journey. Weave’s software solutions transform how healthcare practices attract, communicate with, and engage patients and clients to grow their business. Weave seamlessly integrates billing and payment requests into communication workflows, streamlining payment timelines, reducing accounts receivable, and supporting practice profitability. In the past year, Weave has been named an Inc. Power Partner, a G2 leader in Patient Relationship Management software, and a Top 50 Product for Small Business. To learn more, visit getweave.com/newsroom.

Investor Relations

Mark McReynolds

Head of Investor Relations

ir@getweave.com

Released June 6, 2025